×

Equipment and Services Health Care Equipment and Supplies

  • TRUMP BUDGET PROPOSES TO MORE THAN DOUBLE FEES FOR COMPANIES SEEKING FDA REVIEW OF DRUGS AND MEDICAL DEVICES.

  • NEW YORK, March 13- Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. "They are putting up good numbers from a growth perspective and they seem like they're in a little cocoon from the political drug pricing debate," said Walter Todd, chief investment officer of...

  • WASHINGTON, March 10- The White House is expected as early as Friday to nominate Dr. Scott Gottlieb, a physician and conservative health policy expert, to lead the U.S. Food and Drug Administration, sources familiar with the matter said. If confirmed by the Senate, Gottlieb would be in charge of implementing President Donald Trump's plan to dramatically cut...

  • BENGALURU, March 6- Tech Mahindra Ltd, India's fourth biggest software services exporter, will buy U.S.-based healthcare IT consulting firm CJS Solutions Group for an enterprise value of $110 million. India's $150 billion information technology industry uses H-1B visas to fly engineers and developers to the United States to provide services to clients.

  • SAN FRANCISCO, Feb 28- The University of California, San Francisco on Tuesday laid off 49 information technology employees and outsourced their work to a company based in India, ending a year-long process that has brought the public university under fire. The University of California system, which includes health care and research-focused UCSF, has been...

  • LONDON, Feb 24- A small study in 16 people with severe anorexia has found that implanting stimulation electrodes into the brains of patients could ease their anxiety and help them gain weight. Researchers found that in extreme cases of the eating disorder, the technique- known as deep brain stimulation- swiftly helped many of those studied reduce symptoms of...

  • Boston Scientific sinks on heart valve system recall

    Shares of Boston Scientific sink on a heart valve system recall. CNBC's Meg Tirrell reports.

  • The TAVR market in which Edwards Lifesciences Corp is considered the leader could potentially exceed $5 billion by 2021, and grow 10 percent to 15 percent for the foreseeable future, Leerink analysts said in a note. The Marlborough, Massachusetts- based company had suspended implants of its next-generation Lotus Edge device in Europe last October over...

  • Boston Scientific had suspended implants of its next-generation Lotus Edge device in Europe last October over similar concerns, but last month said it had found a fix for the issue. The company has pushed the submission of its marketing application for the device in the United States to the fourth quarter, and expects to launch it in mid-2018.

  • Feb 23- Boston Scientific Corp said on Thursday it was recalling its Lotus Valve heart devices, citing reports of problems with the locking mechanism, sending its shares down 8 percent in premarket trading. Boston Scientific had suspended implants of another valve system, Lotus Edge, in Europe last October over similar concerns. The company said it continues to...

  • Feb 23- Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices, citing reports of problems with the locking mechanism. The products are expected to return to the European market and in other regions in the fourth quarter, the company added. The company's stock was down 9.4 percent at $22.79 in premarket trading.

  • Feb 21- The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices. Boston Scientific had asked the justices to hear its appeal in the dispute over its licenses...

  • Feb 21- The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

  • TEL AVIV, Feb 21- Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis, a neuro-degenerative disease, even before it completes late-stage clinical trials. At the same time, BrainStorm will conduct a Phase 3 clinical trial for NurOwn at multiple sites in the...

  • A man walks out of the Univista Insurance company office after shopping for a health plan under the Affordable Care Act, on December 15, 2015, in Miami.

    Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.

  • Athletes are going beyond wearable fitness trackers

    "Blueprint for Athletes" is a service by Quest Diagnostics that provides diagnostic insights to help committed athletes improve their performance.

  • What happens during atrial fibrillation

    As many as 6 million Americans have atrial fibrillation, the most common form of cardiac arrhythmia. It’s caused when the electrical signaling that keeps our hearts beating becomes erratic, and, in its most serious forms, can lead to stroke or heart failure.

  • AMSTERDAM, Jan 24- Medical equipment maker Philips missed forecasts for fourth-quarter earnings on Tuesday and disclosed a dispute with the U.S. Justice Department over heart defibrillators it had sold until 2016, but said the matter would not alter its medium term outlook. Van Houten said Philips' defibrillator business would be "impacted" but the scope was...

  • WASHINGTON, Jan 18- Texas- based medical device company Orthofix International NV has admitted wrongdoing and agreed to pay more than $14 million to settle charges that it improperly booked revenue and paid off doctors in Brazil to boost sales, U.S. regulators said on Wednesday. The Securities and Exchange Commission said in a statement that Orthofix...

  • Jan 9- Abbott Laboratories moved to protect patients with its St. Jude heart implants against possible cyber attacks, releasing a software patch on Monday that the firm said will reduce the "extremely low" chance of them being hacked. The patch that Abbott began pushing out to patients on Monday addresses vulnerabilities that present the greatest risk to...